Skip to main content

Year: 2023

Icelandair extends network with new destinations and increased frequency

Icelandair introduces its flight schedule for 2024, the most extensive schedule to date. The Company will offer flights to over 50 destinations, with three connection banks within the day. and daily flights to 28 destinations in Europe and North America, with more than one flight a day to 19 destinations thereof. Halifax and Pittsburgh are new destinations in summer 2024 and frequency will be increased to a number of destinations. Increased connectivity will offer 800 different connections and far more through codeshare agreements with other airlines. In 2024, available seat kilometers (ASK) are expected to increase by at least 10% from the previous year.   Three Boeing 737 MAX 8 aircraft will be added to Icelandair’s fleet in 2024. The Company’s fleet will then consist of 42 aircraft, thereof 21 737 MAX.  Halifax and Pittsburg new destinations...

Continue reading

Earthworks Announces Closing of Private Placement of Units for Gross Proceeds of $1.5 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Nov. 02, 2023 (GLOBE NEWSWIRE) — Earthworks Industries Inc. (TSXV:EWK) (the “Company”) is pleased to announce that it has closed its previously announced commercially reasonable efforts private placement offering of an aggregate of 7,500,000 units (the “Units”) at a price of $0.20 per Unit (the “Issue Price”) for aggregate gross proceeds of $1,500,000 (the “Offering”). Each Unit consists of one common share in the capital of the Company (each, a “Common Share”) and one common share purchase warrant of the Company (each, a “Warrant”). Each Warrant will entitle the holder thereof to purchase one additional Common Share at a price of C$0.40, subject to adjustment in certain events, at any time until November...

Continue reading

Investment Soars in EV Industry: A Worldwide Electrification Trend – Exclusive Report by MarketsandMarkets™

Chicago, Nov. 02, 2023 (GLOBE NEWSWIRE) — Increasing fuel prices and decreased emissions have made EVs a more attractive option in recent years. According to Global EV Outlook, EVs including BEVs & PHEVs, doubled in 2021 and reached 6.6 million units. Despite the supply chain issues and recession across Western countries, Electric cars sales rose strongly in 2022 and exceeded 10 million, ~14% of cars sold were electric. According to IEA, electric car sales are expected to reach 13 million units by the end of 2023. The global automotive industry is shifting towards a greener and sustainable future, so OEMs, system and component suppliers are investing in innovative technologies complying with the changing regulatory landscape. Need For Electric Vehicle Modular Platform Modular EV platforms offer versatility, accommodating...

Continue reading

Global Natural Sweeteners Market Size to Reach USD 6.03 Billion in 2032 | Emergen Research

Rising awareness regarding health benefits of natural sweeteners and adoption of innovative technologies in culinary industry are factors driving market revenue growth Vancouver, Nov. 02, 2023 (GLOBE NEWSWIRE) — The global natural sweeteners market size reached USD 2.9 Billion in 2021 and is expected to register a significantly rapid revenue CAGR during the forecast period, according to latest analysis by Emergen Research. Increasing awareness regarding adverse effects of artificial sweetener related diseases such as obesity and diabetes is one of the major factors expected to drive market revenue growth. Drivers: Natural sweeteners are gaining popularity owing to anti-cariogenic effects, low caloric value, and others. Natural sweeteners are healthier compared to processed sugar and artificial sweeteners as these have additional...

Continue reading

Saga Communications, Inc. Reports 3rd Quarter 2023 Results

GROSSE POINTE FARMS, Mich., Nov. 02, 2023 (GLOBE NEWSWIRE) — Saga Communications, Inc. (Nasdaq – SGA) (the “Company” or “Saga”) today reported that net revenue decreased 2.8% to $29.2 million for the quarter ended September 30, 2023 compared to $30.0 million for the same period last year. Station operating expense increased 2.1% for the quarter to $22.8 million compared to the same period last year. For the quarter, operating income was $3.5 million compared to $1.1 million for the same quarter last year and station operating income (a non-GAAP financial measure) decreased 14.7% to $7.6 million. Capital expenditures were $760 thousand for the quarter compared to $1.2 million for the same period last year. We had net income of $2.7 million for the quarter compared to a net loss of $104 thousand for the third quarter last year....

Continue reading

Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2023 Financial Results

SUMMIT and APEX clinical presentations planned for 2023 ASH Annual Meeting; SUMMIT NonAdvSMdata selected for oral presentation SUMMIT Part I completed upsized enrollment during Q3; SUMMIT Part 2 expected to begin in 1H 2024 at over 50 sites globally 33% ORR and >14 months median duration of treatment for 2nd-line GIST patients from updated PEAK lead-in data presented at 2023 CTOS Annual Meeting Ended Q3 2023 with $312.8 million, providing cash runway into 2026 WALTHAM, Mass. and BOULDER, Colo., Nov. 02, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today reported recent business highlights and financial results for the third quarter ended September 30, 2023. “This quarter was marked by meaningful progress as we...

Continue reading

Global Oncolytic Virus Therapy Market to Reach Value of USD 2,041.05 Million by 2032 | Emergen Research

Growing awareness about early cancer detection is a significant factor driving global oncolytic virus therapy market growth. Vancouver, Nov. 02, 2023 (GLOBE NEWSWIRE) — The global oncolytic virus therapy market size is expected to reach USD 2,041.05 Million at a steady CAGR of 23.9% in 2032, according to latest analysis by Emergen Research. Robust growth of the oncolytic virus therapy market can be attributed to growing geriatric population. Aging is a major factor accountable for cancer incidence, and prevalence increases drastically with age, particularly owing to rise in specific cancer associated risks that increase as individuals grow older and cellular repair mechanisms getting less effective. According to estimation for 2019, around 140,000 cancer cases were diagnosed in the US, and around 103,000 deaths occurred in individuals...

Continue reading

H&H Group posts solid Q3 revenue growth, fuelled by nutritional supplements category

LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) — Leading global health and wellness company H&H Group has announced financial results for the nine months ending 30 September 2023, reporting a positive overall result with its total revenue increasing by 11.9% year-on-year (YoY) on a reported basis (10.9% on a like-for-like (LFL) basis) to RMB10,278.4 million. Staying on course for its full-year 2023 targets, H&H’s third quarter progress was primarily fuelled by robust sales in Adult and Pet Nutrition & Care in mainland China, Australia and New Zealand and North America, while the Baby Nutrition & Care segment continued to face market challenges, mainly in mainland China. New H&H Group CEO Camillo Pane expresses satisfaction with H&H Group’s performance through the first three quarters of 2023, confidently...

Continue reading

Global Li-Fi Market to Reach Value of USD 124,850.71 Million by 2032 | Emergen Research

Rising government focus on smart cities and increasing demand for faster data transmission is driving Li-Fi market growth. Vancouver, Nov. 02, 2023 (GLOBE NEWSWIRE) — The global Li-Fi market is expected to reach a market size of USD 124,850.71 Million by 2032 and register a high revenue CAGR, according to latest analysis by Emergen Research. Rising government focus on smart cities is expected to drive global Li-Fi market growth over the forecast period. Besides, increasing demand for faster data transmission is expected to stimulate global Li-Fi market growth during the forecast period. Decreasing LED prices worldwide is expected to further boost market growth going forward. The use of LEDs is being encouraged worldwide due to low energy consumption and improved lighting. Request Free Sample Copy (To Understand the Complete Structure...

Continue reading

Global Infrared Imaging Market to Reach Value of USD 13.64 Billion by 2032 | Emergen Research

Growing demand for near-infrared imaging in healthcare industry is a significant factor driving global infrared imaging market growth. Vancouver, Nov. 02, 2023 (GLOBE NEWSWIRE) — The global infrared imaging market is expected to reach a market size of USD 13.64 Billion at a steady CAGR of 7.3% in 2032, according to latest analysis by Emergen Research. Increasing demand for infrared imaging can be attributed to growing demand for near-infrared imaging in the healthcare industry. Near-Infrared Spectroscopy offers a portable and affordable means for functional neuroimaging similar to Electroencephalography (EEG), without the need to severely restrict subject motion. Near-infrared spectroscopy is used for detection of vulnerable coronary plaques by identifying the chemical composition of substances on the basis of differential light...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.